In recent years it has become increasingly clear that, alongside genetic risk factors, environmental factors strongly influence the incidence and severity of multiple sclerosis (MS). Based on observations from epidemiological studies, the potential contribution of dietary habits has lately been a matter of debate. Recently it was shown that high salt conditions promote pathogenic T-cell responses and aggravate autoimmunity in an animal model of MS, suggesting that high dietary salt intake might promote central nervous system (CNS) autoimmunity. However, so far, not much is known about the influence of dietary salt intake on MS disease pathology. Here, we discuss the association of dietary salt levels and MS with a special focus on the mechanisms of salt-mediated modulation of the different cell types critically involved in the pathophysiology of MS.
Introduction
Multiple sclerosis (MS) is an autoimmune disease of the central nervous system (CNS) that is characterized by peripheral inflammatory processes, bloodbrain barrier (BBB) breakdown, and immune cell infiltration into the CNS, leading to both axonal damage and demyelination, and ultimately resulting in disability in MS patients. 1 Several genetic risk factors have already been identified, often in immunologically relevant genes. 2 Twin studies, in particular, however, have revealed that there is also a contribution to MS pathogenesis from environmental factors, 3 including viral infections, vitamin D levels, and geographical location. 3, 4 Lately, the contribution of dietary habits to MS disease incidence and severity has become a matter of debate. Specifically, the consumption of a "Western diet," characterized by high levels of fat, cholesterol, protein, sugar and salt, is discussed as a promoter of autoimmunity. 4, 5 Whereas a negative impact of high salt intake has already been acknowledged in other pathophysiological conditions, such as hypertension and cardiovascular diseases, 6, 7 the association between increased salt intake and MS has only recently come into focus. 5
Association of dietary sodium intake with CNS autoimmunity
Although the risk of developing autoimmune diseases such as MS, inflammatory bowel disease, rheumatoid arthritis (RA), and psoriasis has been associated with nutrition, there is, to date, no clear evidence whether the consumption of certain dietary components definitely influences autoimmunity. 5 Two studies have identified high salt as a potential promoter of T-cell-mediated autoimmunity in experimental models of autoimmunity, where a high salt diet causes profound aggravation of clinical signs in the animal model of MS, experimental autoimmune encephalomyelitis (EAE), by promoting pathogenic T-helper 17 responses. 8, 9 In line with this, a recent study evaluating two independent cohorts of MS patients offers the first evidence of a potential association between dietary salt intake, as determined by urine excretion, and MS disease activity. 10 MS patients with an increased dietary salt intake displayed higher relapse rates as well as increased numbers of new MRI lesions compared to patients with moderate dietary salt intake. Of note, serum sodium levels remained relatively constant under different dietary conditions and hence could not be linked to MS disease activity. 10 Although this study indicates an association between dietary salt intake and MS disease activity, causality cannot be claimed from the results. Furthermore, as cohort size was relatively small and the exclusion of confounders was not possible, further well-designed controlled studies are needed to confirm this finding. 10 So far, the impact of increased sodium intake on disease susceptibility or on disease progression in chronic progressive MS forms has not been addressed. A very recent study has demonstrated that, at least in the animal model of MS, dietary sodium can exacerbate CNS autoimmunity in a strain-and sex-specific fashion, thus providing the first experimental evidence of an interaction between genetic and environmental factors in the context of sodium-induced promotion of CNS inflammation. 11 Evidence of a direct influence of dietary salt intake on human immune responses in general is also scarce. In the setting of a spaceflight simulation, a small cohort of healthy human participants (n = 6) who lived in the same environment, consumed the same food, and had the same exercise schedule were delivered a wellcontrolled diet in which only salt content changed over time, while other nutrients remained at a constant level. 12 Monocyte numbers in the blood positively correlated with the amount of dietary salt consumed, i.e. numbers declined significantly when salt intake was reduced. Furthermore, mitogen stimulation of peripheral blood mononuclear cells (PBMCs) revealed that production of interleukin (IL)-6 and IL-23 decreased whereas IL-10 production increased with a reduction in dietary salt intake. In line with this, levels of IL-6 and IL-10 in plasma were reduced and increased, respectively. Although T-cell numbers in the blood did not correlate with the amount of dietary salt consumed, plasma levels of IL-17 decreased with a reduction in dietary salt consumption. 12 Despite their limitations, these results suggest a positive correlation between dietary salt intake and a potential risk of excessive immune responses in humans.
Modulation of peripheral and local (immune) responses by increased sodium levels T cells and myeloid cells play key roles in shaping the local immune response in MS.
It is well accepted that T cells are primed in the periphery before migration to the CNS where they initiate disease. 13 In this context, the differentiation of T-helper 17 cells (Th17) is crucial as these cells are the first to cross the endothelial cell-lined BBB to enter the CNS. 14 Upon interaction with antigen-presenting microglial cells in the CNS, a chemokine cascade is induced that promotes recruitment of further immune cells, including more T cells and inflammatory monocytes. 13 There is growing evidence of complex effects of sodium on the different cellular components involved in the pathogenesis of CNS autoimmunity (summarized in Figure 1 ).
T cells
People who frequently consume fast food have an elevated ratio of pro-inflammatory IL-17 + / anti-inflammatory Foxp3 + T cells in peripheral blood compared to individuals who have a low intake of fast food. 15 Furthermore, levels of IL-17 in plasma correspond to the amount of dietary salt consumed, 12 indicating that dietary salt intake might influence T-cell responses. Studies investigating the effect of hypertonic saline (HS), which is used in the treatment of trauma patients, on human T cells has revealed that HS triggers the activation of mitogen-activated kinase (MAPK) p-38 and increases T-cell proliferation as well as IL-2 production under stimulatory conditions. 16 Additionally, such HS treatment can restore function of suppressed T cells, a phenomenon observed in trauma patients. 17 Under salt-enriched conditions, T cells exhibit significantly increased potential to differentiate into Th17 cells in vitro 8, 9 as well as in vivo during EAE 8, 9 or upon immunization. 18 This increase in Th17 response under high salt conditions is mediated by the activation of p-38 and induction of nuclear factor of activated T cells 5 (NFAT5, also known as tonicity-responsive enhancer bindingprotein (TonEBP)) and serum glucocorticoid kinase-1 (SGK1)). 8, 9 SGK1 is specifically expressed by Th17 cells, and T cell-specific SGK1 knockout reduces the increase in EAE disease severity and Th17 responses observed on a high salt diet. 9 In addition, salt-induced activation of macrophages is also linked to increased Th17 responses under high salt conditions in vivo as high sodium chloride (NaCl) levels induce IL-1β production by macrophages, which contributes to enhanced Th17 differentiation. 18 Although it has been questioned whether the NaCl concentrations used in EAE studies are unphysiological compared to tissue osmolarities, 19 it has been shown that comparable sodium concentrations do occur in the skin of rats that have been fed a high salt diet. 20 Considered together, these studies suggest that increased NaCl levels can alter the differentiation potential of T cells into autoreactive T cells, which in turn may contribute to enhanced CNS autoimmunity.
Myeloid cells
Pro-inflammatory myeloid cells, i.e. monocytes, macrophages and CNS-resident microglial cells, play an important role in the establishment and perpetuation of CNS inflammation. 21, 22 Several studies show that high salt conditions promote myeloid cell activation in vitro. Addition of high concentrations of NaCl to macrophages promotes the phosphorylation of members of the MAPK pathway, i.e. c-Jun amino-terminal kinase (JNK), p-38, and extracellular signal-regulated kinase (ERK). This phenomenon is also induced by sorbitol and, as such, might be a general feature of macrophage response to hyperosmolaric conditions. 23 Functionally, enhanced phosphorylation of p-38 and p-38-dependent NFAT5 signaling promotes increased production of nitric oxide and tumor necrosis factoralpha (TNF-α), which boost the capacity of macrophages to clear bacterial infection. 24 Interestingly, patients with bacterial skin infections exhibit increased tissue accumulation of Na + , suggesting that local high salt conditions might contribute to local pro-inflammatory macrophage activation. 24 Furthermore, high NaCl conditions activate caspase-1 leading to IL-1α and IL-1β production upon lipopolysaccharide (LPS) stimulation that also contributes to enhanced induction of Th17 responses in vivo under high salt diet conditions. 18 A very recent study has extended these findings by demonstrating that high salt potentiates LPS-induced macrophage activation both in vitro and in an LPS-mediated acute lung injury model in vivo. 25 In line with these observations, we have confirmed that NaCl-treatment induces a proinflammatory phenotype in macrophages in vitro and under high salt diet in vivo. Importantly, such NaCl-treated macrophages are capable of aggravating ongoing EAE (own unpublished data). Besides cytokines, macrophages also produce enhanced levels of chemokines, namely macrophage inflammatory protein-2 18, 26 and CCL2, 18, 27 which strongly depend on the salt condition used. CCL2 in particular plays an important role in the recruitment of monocytes to the CNS during EAE. 21 Salt-sensing kinases, i.e. sucrose nonfermenting-1related serine/threonine kinase and SGK1, act as sensors of extracellular Na + gradients. 28 Inflammatory stimulation induces SGK1 expression in THP-1 monocytes 29 and potentially contributes to a proinflammatory phenotype. Conversely, inhibition of salt-inducible kinases induces macrophages with an anti-inflammatory phenotype, producing increased amounts of IL-10 and decreased amounts of proinflammatory cytokines. 30 Although the kidney has been regarded as the central regulator of salt and water regulation in the body, recent studies show that Na + is stored in the skin and that macrophages are attracted to tissues with high Increased sodium chloride (NaCl) levels promote pro-inflammatory T cell (1) and macrophage (2) responses that are associated with excessive immune responses in CNS autoimmunity. NaCl-treatment induces p-38 signaling in CD4 + T cells, which leads to increased differentiation into pathogenic Th17 via activation of NFAT5 and SGK1 (1). In macrophages, NaCl activates the MAPK signaling pathway, which promotes production of pro-inflammatory cytokines and nitric oxide (2) . Furthermore, NaCl-treated macrophages produce chemokines and IL-1b, which contribute to increased Th17 responses in vivo (2) . Also endothelial cells, which are in close contact with plasma sodium levels, are activated in response to increased NaCl levels (3) . Activation is characterized by enhanced expression of adhesion molecules (E-Selectin, VCAM-1) and production of chemokine CCL2, all of which facilitates adhesion of leukocytes and transmigration into the target tissue. MAPK: mitogen-activated kinase; CNS: central nervous system; NFAT5: tonicity-responsive enhancer binding-protein; SGK1: serum glucocorticoid kinase-1; IL: interleukin; Th17: T-helper 17 cells; VCAM-1: vascular cell adhesion molecule 1. salt content, where they regulate electrolyte composition. 20 Interestingly, macrophages sense high salt conditions as a chemotactic stimulus and show increased migration toward NaCl high conditions, especially at concentrations corresponding to those observed in rats fed a high salt diet. Such migration is not observed toward other hyperosmolaric substances, indicating that this chemotaxis effect is salt specific. 27 In line with these in vitro findings, intraperitoneal injection of hypertonic NaCl induces an influx of inflammatory monocytes into the peritoneal cavity in vivo. 18 Taken together, these studies show that extracellular sodium levels influence myeloid cell responses by promoting a pro-inflammatory phenotype, which may contribute to the aggravation of CNS autoimmunity.
Epithelial cells
The intestinal epithelial barrier plays an important role in maintaining tolerance to self-antigen. Alteration of intestinal permeability by industrial food additives, such as high amounts of salt, might contribute to the rising incidence of autoimmune diseases. 31 In vivo data on the influence of salt on the integrity of the intestinal barrier is lacking. However, in vitro data show that induction of Na + -glucose co-transport in a human colon epithelial cell line results in activation of the Na + /H + exchanger 3, which mediates Na + absorption in the small intestine, 32 as well as modulation of tight junction-associated proteins. 33 As these events increase intestinal permeability, entry of foreign immunogenic antigens might be facilitated that could, in turn, contribute to the induction of autoimmune processes. 31 Furthermore, hyperosmolaric treatment of epithelial cells induces the production of pro-inflammatory cytokines that is mediated by activation of the MAPK pathway. 34 
Endothelial cells
Endothelial cells are in physical contact with plasma sodium and respond even to small but physiologically relevant increases in sodium by acquiring a stiff morphology, which potentially affects their function. 35 Under shear stress conditions in vitro, addition of NaCl increases the responsiveness to TNFα of human endothelial cells, which is characterized by enhanced expression of adhesion molecules E-selectin and vascular cell adhesion molecule 1 (VCAM-1) as well as increased THP-1 monocyte cell adhesion. 36 Pronounced activation under increased salt conditions is mediated by the induction of reactive oxygen species, nuclear factor kappa-B (NF-kB) and NFAT5 (Ton-EBP). ApoE mice receiving high saltwater exhibit enhanced adhesion of circulating CD11b + cells to the carotid bifurcation, indicating that also in vivo, myeloid cells adhere better to salt-activated endothelial cells. 36 Under saltwater treatment, E-selectin and VCAM-1 are highly upregulated on murine endothelial cells in vivo. In addition, CCL2 (MIP1) is strongly upregulated, 37 which promotes leukocyte adhesion to the brain microvasculature 38 and facilitates transmigration into tissues. 39 Together, these studies indicate that sodium alters the phenotype of endothelial cells, which in turn might also promote immune cell infiltration in the setting of CNS autoimmunity.
Microbiota
Despite this broad evidence of immune-modulatory effects of sodium on different cellular components involved in the pathogenesis of CNS autoimmunity, the question remains as to how increased dietary sodium intake can be linked to the development of autoimmunity, especially in light of the fact that serum sodium levels are very tightly regulated and do not correlate with increased dietary sodium intake. 10 One hypothesis that has recently gained much attention is that a high salt diet might influence the gut microbiome composition and hence the development of autoimmunity. 40, 41 The intestinal microflora is not only a prerequisite for establishment of CNS autoimmunity 42 but influences pro-inflammatory 43 as well as regulatory T-cell responses in EAE. [44] [45] [46] Interestingly, the human microbiome adapts very quickly to a new diet. Changing diet for five consecutive days to a plant-based or animal-based diet is sufficient to alter the microbiome composition. 47 In a mouse model in which human fecal microbial communities were transplanted into germ-free mice, the animals' diet was changed from a low-fat, plant polysacchariderich diet to a diet rich in fat and sugar, i.e. a "Western diet," once colonization was established. Within one day, the composition of microbiota as well as the expression of genes associated with metabolic pathways changed. 48 When administered a westernized diet rich in fat and sugar and low in vitamins B and D, mice developed obesity accompanied by an increase in the frequency of Th17 cells. 15 Importantly, coadministration of a Western diet and probiotic bacteria in drinking water inhibited obesity by induction of regulatory T cells and IL-10, 15 which has proven also beneficial in EAE. 44, 45 Taken together, these studies indicate that salt could promote the development of CNS autoimmunity, at least partly by changing the gut microbiome. It is hence an attractive, although still unproven, concept that targeted corrections of the gut microbiome via the diet, e.g. reducing salt intake and adding particular probiotic bacteria might exert beneficial effects on disease activity in autoimmune diseases including MS. This research will certainly gain more interest in the next years, and specific dietary interventions will help to clarify the picture. However, it should be noted that an increase in sodium intake alone in the absence of any other feature of a typical Western diet is obviously not sufficient for an increased risk of CNS autoimmunity as countries with a traditionally high salt intake, i.e. Japan and China, have a low rate of MS incidence compared to Western countries. 49
Concluding remarks
In many societies, the average daily salt intake by far exceeds physiological demands. 36 It is well known that elevated dietary salt consumption is associated with an increased risk of developing cardiovascular diseases, 50, 51 whereas even a moderate reduction in salt intake decreases this risk by 25%-30%. 52 With regard to the promotion of inflammation and autoimmunity, increased dietary salt intake has only recently come into focus. 5 Although there is some indication that elevated sodium intake might have a detrimental role in MS disease activity, well-controlled largescale studies providing substantial evidence for the pathophysiological relevance of enhanced salt intake in exacerbating human (auto-)immune responses are still lacking. Furthermore, whether a reduction in salt intake as an add-on to immune-modulatory therapies will prove beneficial in interfering with MS disease activity remains to be proven. Hence, it will be necessary to carry out well-designed clinical studies with a sufficient cohort size to address the relevance of the direct, as well as indirect, effects of increased salt intake on immune responses on humans and their impact on disease activity in MS. In addition, it will be necessary to investigate in controlled clinical studies whether a reduction in dietary salt intake proves beneficial in MS and other autoimmune diseases. Such a dietary intervention in humans appears feasible, and this approach represents a highly attractive concept for a complementary treatment in MS patients in addition to standard medical care; however, its benefit still needs to be proven.
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